Press release
COVID-19 Drug Associated APIs Global Market Rising Trends, Industry Size, Share Report, Growing Demand and Business Opportunities And Forecast 2024-2033
The covid-19 drug associated apis market size has grown strongly in recent years. It will grow from $6.37 billion in 2023 to $6.75 billion in 2024 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to rising prevalence of covid-19, increasing awareness of covid-19 treatment options, expanding access to covid-19 drugs, growing demand for covid-19 drugs for prophylaxis, government initiatives, supply chain resilience.The covid-19 drug associated apis market size is expected to see strongly grown in the next few years. It will grow to $8.52 billion in 2028 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to development of new covid-19 drug modalities, increasing clinical trials for covid-19 drugs, rising demand for covid-19 vaccines, emerging variants, vaccination campaigns, pandemic preparedness. Major trends in the forecast period include customized api production, diversification of api sources, advanced manufacturing technologies, digitalization and data analytics, sustainability and green chemistry.
Market Overview -
COVID-19 drug-associated APIs refer to the active pharmaceutical components that are employed in the production of COVID-19 medications. Chemicals called active pharmaceutical components serve as the foundation for pharmaceutical drugs and medicines and are responsible for pharmacological activity in the human body.
Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=3248&type=smp
Elevated Demand For Active Pharmaceutical Ingredients (APIS) Driven By Antivirals, Antimalarials, And Respiratory Medications In The Covid-19 Drug Market
High demand for antiretrovirals, antimalarials, sedatives, bronchodilators, and other respiratory drugs drives the demand for the active pharmaceutical ingredients (APIs) used in the production of COVID-19 drugs. Active pharmaceutical ingredients (APIs) are the biologically active components used in manufacturing pharmaceutical drugs. Remdesivir and Favipiravir are two common antiviral medications used currently for the treatment of COVID-19 patients. Remdesivir is a medication approved for emergency use in the USA and Japan for the treatment of COVID-19 patients. FDA has approved Airsupra (albuterol and budesonide) inhalation aerosol for the as-needed treatment or prevention of bronchoconstriction and to reduce the risk of asthma attacks in patients with asthma 18 years of age and older. Favipiravir, which is used to treat influenza in Japan, has also shown a positive effect on COVID-19 patients. As COVID-19 is a respiratory ailment, the demand for bronchodilators spiked significantly. Therefore, the increasing demand for antivirals, antimalarials, and bronchodilators is projected to boost the demand for the COVID-19 drug associated APIs market over the forecast period.
Competitive Landscape -
Major companies operating in the covid-19 drug associated apis market include Dr. Reddy's Laboratories Ltd., Lianyungang Guike Pharmaceutical CO. LTD., Alembic Pharmaceuticals Ltd., Wockhardt Ltd., Sandoz Srl, Lupin Limited, Aurobindo Pharma Ltd., Shanghai Shyndec Pharmaceutical Co. Ltd., Zhejiang Yatai Pharmaceutical Co. Ltd., Zhejiang Guobang Pharmaceutical Co Ltd., Cipla Limited, Shandong Boyuan Pharmaceutical Co. Ltd., Aspiro Pharma Ltd., Qilu Antibiotics Pharmaceutical Co. Ltd., Shenzhen China Resources Jiuxin Pharmaceutical Co. Ltd., Zhejiang Cheng Yi Pharmaceutical, Star Lake Bioscience Co.Inc., Hetero Labs Ltd., Geno Pharmaceuticals Ltd., Mylan Laboratories Ltd., Ipca Laboratories Limited, Zydus Takeda Healthcare Private Limited, Mangalam Drugs & Organics, Wallace Pharmaceuticals, Zhejiang Hisun Pharmaceutical Co. Ltd., Zhejiang Huahai Pharmaceutical Co. Ltd., Zhejiang Jiuzhou Pharmaceutical Co. Ltd., Zhejiang NHU Co. Ltd., Zhejiang Xianju Pharmaceutical Co. Ltd., Zhejiang Yongtai Technology Co. Ltd., Zhejiang Zhebei Pharmaceutical Co. Ltd., Zhejiang Tianyu Pharmaceutical Co. Ltd., Zhejiang Aisheng Pharmaceutical Co. Ltd., Zhejiang Aokang Pharmaceutical Co. Ltd., Zhejiang Anji Huifeng Surgical Dressings Co. Ltd.
Pharmaceutical Industry's Strategic Expansion In Api Production To Meet Surging Demand For Covid-19 Drugs
Key players operating in the pharmaceutical industry that manufacture COVID-19 drug-associated APIs are focusing on strategies such as plant capacity or production capacity expansion to meet the increasing demand due to the rising number of coronavirus cases across the globe. For instance, in October 2023, Merck & Co., Inc., a US-based pharmaceutical company, with a recent partnership with the Heavy Water Board in India, hopes to tap into the deuterated raw compound industry, which is presently worth around $100 million and has the potential to rise to $1 billion over the next five to ten years. Merck seeks to support India's chemical, pharmaceutical, and technical sectors by offering high-quality compounds for the manufacture of medicines, semiconductors, OLEDs, and electronics. Avigan is currently undergoing clinical trials testing its safety and efficacy for the treatment of COVID-19 patients.
Browse Full Report @
https://www.thebusinessresearchcompany.com/report/covid19-drug-associated-api-global-market-report
Key Segments -
The covid-19 drug associated apis market covered in this report is segmented -
1) By Drug Class: Antimalarials, Bronchodilators, Antibiotics, Antivirals, Other Drug Class
2) By Synthesis Type: Synthetic, Biotech
3) By Business Mode: Captive API, Merchant API
Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.
Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release COVID-19 Drug Associated APIs Global Market Rising Trends, Industry Size, Share Report, Growing Demand and Business Opportunities And Forecast 2024-2033 here
News-ID: 3476130 • Views: …
More Releases from The Business research company
Segmentation, Major Trends, and Competitive Overview of the Business Card Scanni …
The business card scanning software industry is on the brink of remarkable expansion, driven by evolving work environments and technological advancements. As businesses increasingly rely on digital tools for managing contacts and leads, this sector is set to witness substantial growth and innovation. Below is an overview of the market size, key players, emerging trends, and segmentation shaping the future of this dynamic industry.
Forecasted Market Expansion for Business Card Scanning…
Leading Companies Fueling Innovation and Growth in the Body Area Network Market
The body area network market is rapidly evolving, driven by advancements in healthcare technology and increasing demand for connected health solutions. This sector is set to experience substantial growth as personalized and remote patient monitoring becomes more prevalent. Let's explore the market size, key players, emerging trends, and the main segments shaping the future of body area networks.
Market Size and Expansion Prospects for the Body Area Network Market
The body…
Key Strategic Developments and Emerging Changes Shaping the Blockchain in Teleco …
The telecom sector is undergoing a technological transformation with blockchain emerging as a game-changing solution. This innovation is set to redefine how telecom companies manage data security, transactions, and network operations. Let's explore the current landscape, key players, market drivers, and future trends shaping the blockchain in telecom industry.
Forecasted Market Value of the Blockchain in Telecom Sector by 2030
The blockchain in telecom market is predicted to experience remarkable expansion…
Blockchain Gaming Market Overview, Key Trends, and Insights on Major Players
The blockchain gaming sector is rapidly evolving, drawing significant attention from investors, developers, and gamers alike. This emerging market combines the immersive experience of gaming with the transparency and security of blockchain technology, paving the way for innovative gameplay and new economic models. Let's explore the projected market size, key players, influential trends, and segmentation within this dynamic industry.
Projected Growth and Market Size of Blockchain Gaming by 2030
The blockchain…
More Releases for Pharma
Schizophrenia Market: Expanding Revenue Landscape to 2034 - DelveInsight | Teva …
The Key Schizophrenia Companies in the market inlclude - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Reviva Pharmaceuticals, and others.
DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2034" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed insights into the disease, including historical and projected epidemiology, helping stakeholders understand the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…
